Training program for pediatric clinical pharmacologists
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
['FUNDING_TRAINING'] · DUKE UNIVERSITY · NIH-11092205
This program at Duke University and UNC Chapel Hill is for doctors and pharmacists who want to specialize in how medicines work for kids, giving them hands-on training to help improve drug safety and development for children.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-11092205 on ClinicalTrials.gov |
What this research studies
This program at Duke University and UNC Chapel Hill trains postdoctoral fellows in pediatric clinical pharmacology, focusing on drug discovery, development, and safety for children. It aims to address the high demand for pediatric clinical pharmacologists by providing a comprehensive two-year training experience. Trainees will work under the guidance of experienced mentors and utilize advanced technologies in a collaborative environment. The program is designed for MDs and PharmDs looking to specialize in pediatric pharmacology.
Who could benefit from this research
Good fit: Ideal candidates for this program are MDs in pediatric specialties or PharmDs seeking advanced training in pediatric clinical pharmacology.
Not a fit: Patients who are not involved in pediatric clinical pharmacology training or do not require specialized pediatric drug therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the availability of trained pediatric clinical pharmacologists, improving drug safety and efficacy for children.
How similar studies have performed: Previous iterations of this training program have shown success in developing skilled pediatric clinical pharmacologists, indicating a strong foundation for continued success.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GONZALEZ, DANIEL — DUKE UNIVERSITY
- Study coordinator: GONZALEZ, DANIEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.